HOB Biotech Group Corp Ltd (688656) - Total Liabilities

Latest as of March 2026: CN¥86.13 Million CNY ≈ $12.60 Million USD

Based on the latest financial reports, HOB Biotech Group Corp Ltd (688656) has total liabilities worth CN¥86.13 Million CNY (≈ $12.60 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

HOB Biotech Group Corp Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how HOB Biotech Group Corp Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is HOB Biotech Group Corp Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

HOB Biotech Group Corp Ltd Competitors by Total Liabilities

The table below lists competitors of HOB Biotech Group Corp Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥1.83 Billion
Shandong Bohui Paper Industry Co Ltd SHG:600966	China	CN¥17.07 Billion
Amerant Bancorp Inc. NYSE:AMTB	USA	$8.84 Billion
DBV Technologies S.A. PA:DBV	France	€58.50 Million
MetroCity Bankshares NASDAQ:MCBS	USA	$4.13 Billion
Plymouth Industrial REIT Inc NYSE:PLYM	USA	$1.02 Billion
AcadeMedia AB (publ) ST:ACAD	Sweden	Skr16.12 Billion
ScanSource Inc NASDAQ:SCSC	USA	$899.50 Million

Liability Composition Analysis (2016–2025)

This chart breaks down HOB Biotech Group Corp Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688656 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how HOB Biotech Group Corp Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for HOB Biotech Group Corp Ltd (2016–2025)

The table below shows the annual total liabilities of HOB Biotech Group Corp Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥111.30 Million ≈ $16.29 Million	-49.56%
2024-12-31	CN¥220.67 Million ≈ $32.29 Million	+59.30%
2023-12-31	CN¥138.52 Million ≈ $20.27 Million	-16.04%
2022-12-31	CN¥164.99 Million ≈ $24.14 Million	+75.67%
2021-12-31	CN¥93.92 Million ≈ $13.74 Million	+4.33%
2020-12-31	CN¥90.02 Million ≈ $13.17 Million	-32.59%
2019-12-31	CN¥133.54 Million ≈ $19.54 Million	+44.99%
2018-12-31	CN¥92.10 Million ≈ $13.48 Million	+41.27%
2017-12-31	CN¥65.20 Million ≈ $9.54 Million	-4.04%
2016-12-31	CN¥67.94 Million ≈ $9.94 Million	--

About HOB Biotech Group Corp Ltd

SHG:688656 China Medical Devices

Market Cap

$979.53 Million

CN¥6.69 Billion CNY

Market Cap Rank

#9159 Global

#2328 in China

Share Price

CN¥105.45

Change (1 day)

+0.83%

52-Week Range

CN¥96.69 - CN¥213.11

All Time High

CN¥213.11